We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Histologic Features Guide Prognosis of Childhood Medulloblastomas

By LabMedica International staff writers
Posted on 20 Nov 2008
Specific histologic features of childhood tumors called medulloblastomas may provide insight into prognoses. More...


Medulloblastomas are common, malignant, embryonal tumors in the cerebellum. Individual histologic features such as nodules, balls, or high cell density are used to divide the tumors into variants thought to modify survival estimates.

Scientists found a difference in survival distribution for six features of medulloblastomas: high cell density, fine fibrillary stroma, necrosis, nodules, balls, and prominent nucleoli. The presence of nodules, balls, fine fibrillary stroma, and high cell density improved the survival outlook, whereas necrosis and prominent nucleoli worsened it.

The World Health Organization (WHO; Geneva, Switzerland) classification of these tumors includes desmoplastic/nodular (DM), medulloblastoma with extensive nodularity (N), large cell medulloblastoma (LC), and anaplastic medulloblastoma (A).

"The presence of nodularity in medulloblastoma is important to improved survival likelihood, particularly when combined with balls and fine fibrillary stroma,” wrote Dr. Floyed H. Giles M.D. from the neuropathology department at the Children's Hospital, Los Angeles, (Los Angeles, CA, USA) and colleagues in an article published in the November 13, 2008, issue of the journal Pediatric and Developmental Pathology. "Given the WHO-acknowledged ‘overlap' of desmoplastic/nodular medulloblastoma and nodular medulloblastoma, we suggest these diagnoses be combined into a diagnosis of nodular medulloblastoma, with nodules, balls, and fine fibrillary stroma as defining criteria.”

The investigators contend that three histologic features vital for LC and A diagnoses--large and intermediate size nuclei and prominent nucleoli--have poor read-reread reliability and suggest these be combined into a diagnosis of anaplastic/large cell medulloblastoma.

Related Links:
World Health Organization
Children's Hospital Los Angeles



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Graphical Abstract (Emery, J. K., V. Nemidkanam, N. Colon, et al. Journal of Extracellular Vesicles (2026). https://doi.org/10.1002/jev2.70286)

Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori

Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.